Skip to main content
. Author manuscript; available in PMC: 2023 Nov 28.
Published in final edited form as: Hepatology. 2021 Aug;74(2):961–972. doi: 10.1002/hep.31783

TABLE 2.

Maximal PDR Peak and cPDR20 by 21-Day Outcomes

Outcome
21-Day TFS 21-Day
Nonsurvivor
Primary outcome* n = 23 n = 12
Day 1 mean PDR peak (%/hour [SD]) 10.2 (7.8) 1.9 (0.6)
Difference in means (90% CI) 8.3 (4.4, 12.1)
P value <0.0001
Secondary outcomes* n = 35 n = 21
Day 1 or 2 mean PDR peak (%/hour [SD]) 9.1 (6.8) 2.3 (0.9)
Difference in means (90% CI) 6.8 (4.8, 8.8)
P value <0.0001
Day 1 or 2 mean cPDR20 (%/hour [SD]) 1.4 (1.3) 0.2 (.2)
Difference in means (90% CI) 1.2 (0.8, 1.6)
P value <0.0001
*

Two participants missing outcome due to consent withdrawal and lost to follow-up.

Data reported as mean (SD).

P value is based on a two-sided Student t test at an alpha level of 0.10.